Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen L Lightfoot

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|September 20, 2012
Target mRNA inhibition by oligonucleotide drugs in manHelen L Lightfoot, Jonathan Hall
Nucleic Acids Research|September 19, 2014
Endogenous polyamine function--the RNA perspectiveHelen L Lightfoot, Jonathan Hall
British Journal of Pharmacology|January 11, 2023
Targeting RNA with small molecules-A safety perspectiveHelen L Lightfoot, Graham F Smith
Future Medicinal Chemistry|October 2, 2015
Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeuticsMirjam Menzi, Helen L Lightfoot, Jonathan Hall
ACS Medicinal Chemistry Letters|February 21, 2019
Evolution of Small Molecule Kinase DrugsHelen L Lightfoot, Frederick W Goldberg, Joerg Sedelmeier
Organic & Biomolecular Chemistry|October 13, 2016
Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processingHelen L Lightfoot, Eric A Miska, Shankar Balasubramanian
FEBS Letters|July 21, 2019
The diverse structural landscape of quadruplexesHelen L Lightfoot, Timo Hagen, Natalie J Tatum, et al.
ACS Omega|August 29, 2019
Site-Specific Fluorophore Labeling of Guanosines in RNA G-QuadruplexesTimo Hagen, Anna L Malinowska, Helen L Lightfoot, et al.
Current Pharmaceutical Biotechnology|June 12, 2018
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular CarcinomaRyan L Setten, Helen L Lightfoot, Nagy A Habib, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 21, 2022
High-throughput detection of metal contamination in HTS outputsCorinne Molyneux, Ian Sinclair, Helen L Lightfoot, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|September 20, 2012
Target mRNA inhibition by oligonucleotide drugs in manHelen L Lightfoot, Jonathan Hall
Nucleic Acids Research|September 19, 2014
Endogenous polyamine function--the RNA perspectiveHelen L Lightfoot, Jonathan Hall
British Journal of Pharmacology|January 11, 2023
Targeting RNA with small molecules-A safety perspectiveHelen L Lightfoot, Graham F Smith
Future Medicinal Chemistry|October 2, 2015
Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeuticsMirjam Menzi, Helen L Lightfoot, Jonathan Hall
ACS Medicinal Chemistry Letters|February 21, 2019
Evolution of Small Molecule Kinase DrugsHelen L Lightfoot, Frederick W Goldberg, Joerg Sedelmeier
Organic & Biomolecular Chemistry|October 13, 2016
Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processingHelen L Lightfoot, Eric A Miska, Shankar Balasubramanian
FEBS Letters|July 21, 2019
The diverse structural landscape of quadruplexesHelen L Lightfoot, Timo Hagen, Natalie J Tatum, et al.
ACS Omega|August 29, 2019
Site-Specific Fluorophore Labeling of Guanosines in RNA G-QuadruplexesTimo Hagen, Anna L Malinowska, Helen L Lightfoot, et al.
Current Pharmaceutical Biotechnology|June 12, 2018
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular CarcinomaRyan L Setten, Helen L Lightfoot, Nagy A Habib, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 21, 2022
High-throughput detection of metal contamination in HTS outputsCorinne Molyneux, Ian Sinclair, Helen L Lightfoot, et al.
Pageof 2